$EVMN insider trading
Over the last 12 months, Evommune insiders reported 6 buys totaling $70.2M and 9 sales totaling $2.3M across SEC Form 4 filings. 60% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $70.2M 6 events
- Sold · 12m
- $2.3M 9 events
- Events · 12m
- 15 Form 4 filings, grouped
- Insiders · 12m
- 11 distinct reporters
- 10b5-1 share
- 60% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Carver KyleChief Financial Officer · O | ▲ Buy | 1,000 | $13.26 | $13K | +1.7% | — |
| Jul 7, 2026 | KIRSCH ARTHUR SD | ▲ Buy | 10,000 | $13.3 | $133K | — | indirect |
| Jun 22, 2026 | Drew Janice SuzannChief of Dev. Operations · O | ▼ Sale | 20,000 | $22.63 | $453K | -22.8% | plan |
| Jun 22, 2026 | Patel Jeegar PravinkumarChief Scientific Officer · O | ▼ Sale | 1,488 | $22.5 | $33K | -3.1% | plan |
| Jun 22, 2026 | Pena Luis C.President & CEO · O·D | ▼ Sale | 7,438 | $22.71 | $169K | -1.2% | plan |
| Jun 2, 2026 | Cohen David ED | ▼ Sale | 600 | $21.38 | $13K | -3.3% | plan |
| Jun 2, 2026 | Cohen David ED | ▼ Sale | 5,456 | $20.21 | $110K | -23.1% | plan |
| Jun 1, 2026 | Patel Jeegar PravinkumarChief Scientific Officer · O | ▼ Sale | 16,687 | $22.74 | $379K | -26.4% | plan |
| Jun 1, 2026 | Pena Luis C.President & CEO · O·D | ▼ Sale | 16,787 | $22.74 | $382K | -2.6% | plan |
| May 28, 2026 | Moss Gregory S.Chief Business & Legal Officer · O | ▼ Sale | 14,223 | $22.83 | $325K | -18.9% | plan |
| May 28, 2026 | Carver KyleChief Financial Officer · O | ▼ Sale | 18,175 | $22.84 | $415K | -23.4% | plan |
| Dec 19, 2025 | Hopfner Robert LorneD·10% | ▲ Buy | 1,000 | $17.35 | $17K | +33% | indirect |
| Nov 7, 2025 | Verduyn-van Weegen Felice IsabelD·10% | ▲ Buy | 1,562,500 | $16 | $25.0M | +46.4% | indirect |
| Nov 7, 2025 | LSP 7 Cooperative UA10% | ▲ Buy | 1,562,500 | $16 | $25.0M | +46.4% | — |
| Nov 7, 2025 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▲ Buy | 1,250,000 | $16 | $20.0M | — | 2 tranches · indirect |
Every $EVMN filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Evommune filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $EVMN feed.